vs
Side-by-side financial comparison of Dexcom (DXCM) and SouthState Bank Corp (SSB). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $661.7M, roughly 1.9× SouthState Bank Corp). SouthState Bank Corp runs the higher net margin — 34.1% vs 21.2%, a 12.9% gap on every dollar of revenue. Over the past eight quarters, SouthState Bank Corp's revenue compounded faster (37.4% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
SouthState Bank, based in Winter Haven, Florida, is an American bank and a subsidiary of SouthState Corporation, a bank holding company. As of May 26, 2025, the company had 371 branches in South Carolina, North Carolina, Georgia, Florida, Alabama, Virginia, Colorado and Texas.
DXCM vs SSB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $661.7M |
| Net Profit | $267.3M | $225.8M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 15.1% |
| Net Margin | 21.2% | 34.1% |
| Revenue YoY | 21.6% | — |
| Net Profit YoY | 153.6% | 153.5% |
| EPS (diluted) | $0.67 | $2.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $661.7M | ||
| Q4 25 | $1.3B | $581.1M | ||
| Q3 25 | $1.2B | $599.7M | ||
| Q2 25 | $1.2B | $577.9M | ||
| Q1 25 | $1.0B | $544.5M | ||
| Q4 24 | $1.1B | $369.8M | ||
| Q3 24 | $994.2M | $351.5M | ||
| Q2 24 | $1.0B | $350.3M |
| Q1 26 | $267.3M | $225.8M | ||
| Q4 25 | $267.3M | $247.7M | ||
| Q3 25 | $283.8M | $246.6M | ||
| Q2 25 | $179.8M | $215.2M | ||
| Q1 25 | $105.4M | $89.1M | ||
| Q4 24 | $151.7M | $144.2M | ||
| Q3 24 | $134.6M | $143.2M | ||
| Q2 24 | $143.5M | $132.4M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | 15.1% | ||
| Q4 25 | 25.6% | 54.3% | ||
| Q3 25 | 20.1% | 53.6% | ||
| Q2 25 | 18.4% | 48.8% | ||
| Q1 25 | 12.9% | 22.3% | ||
| Q4 24 | 17.0% | 50.7% | ||
| Q3 24 | 15.3% | 53.1% | ||
| Q2 24 | 15.7% | 49.3% |
| Q1 26 | 21.2% | 34.1% | ||
| Q4 25 | 21.2% | 42.6% | ||
| Q3 25 | 23.5% | 41.1% | ||
| Q2 25 | 15.5% | 37.2% | ||
| Q1 25 | 10.2% | 16.4% | ||
| Q4 24 | 13.6% | 39.0% | ||
| Q3 24 | 13.5% | 40.7% | ||
| Q2 24 | 14.3% | 37.8% |
| Q1 26 | $0.67 | $2.28 | ||
| Q4 25 | $0.67 | $2.47 | ||
| Q3 25 | $0.70 | $2.42 | ||
| Q2 25 | $0.45 | $2.11 | ||
| Q1 25 | $0.27 | $0.87 | ||
| Q4 24 | $0.37 | $1.88 | ||
| Q3 24 | $0.34 | $1.86 | ||
| Q2 24 | $0.35 | $1.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $2.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $9.0B |
| Total Assets | $6.3B | $68.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $2.9B | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | $2.7B | $9.0B | ||
| Q4 25 | $2.7B | $9.1B | ||
| Q3 25 | $2.7B | $9.0B | ||
| Q2 25 | $2.6B | $8.8B | ||
| Q1 25 | $2.3B | $8.6B | ||
| Q4 24 | $2.1B | $5.9B | ||
| Q3 24 | $2.0B | $5.9B | ||
| Q2 24 | $2.4B | $5.7B |
| Q1 26 | $6.3B | $68.0B | ||
| Q4 25 | $6.3B | $67.2B | ||
| Q3 25 | $7.5B | $66.0B | ||
| Q2 25 | $7.3B | $65.9B | ||
| Q1 25 | $6.8B | $65.1B | ||
| Q4 24 | $6.5B | $46.4B | ||
| Q3 24 | $6.4B | $46.1B | ||
| Q2 24 | $6.8B | $45.5B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
SSB
| Net Interest Income | $561.6M | 85% |
| Noninterest Income | $100.1M | 15% |
